V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10380491 | 10056739 | 1.72 | null | Palliative (P) | 2022-01-17 | 2022-01-24 | null | 99 | N | CETUXIMAB | 100357870 |
| 10380513 | 10056740 | 1.7 | 55.1 | null | 2016-10-27 | 2016-11-14 | Bortezomib + Cyclophos + Dex | 02 | null | BORTEZOMIB + CYCLOPHOSPHAMIDE | 101129962 |
| 10380576 | 10056741 | 1.53 | 76.2 | Adjuvant (A) | 2020-03-12 | 2020-03-12 | CYCLOPHOSPHAMIDE | 02 | N | CYCLOPHOSPHAMIDE | 101694877 |
| 10380662 | 10056743 | null | 85 | null | 2018-07-19 | 2018-08-08 | CHLORAMBUCIL + OBINUTUZUMAB | 02 | null | CHLORAMBUCIL + OBINUTUZUMAB | 101084464 |
| 10380704 | 10056744 | 1.71 | 50.5 | null | 2019-09-23 | 2019-09-23 | Bortezomib +/- Dexamethasone | 02 | null | BORTEZOMIB | 101684018 |
| 10380779 | 10056746 | 1.55 | 62.7 | null | null | 2022-04-28 | Bortezomib + Panobinostat | 02 | null | BORTEZOMIB + PANOBINOSTAT | 101083140 |
| 10381031 | 10056748 | 1.57 | 54.9 | null | 2016-02-22 | 2016-03-09 | Niraparib | 02 | null | CISPLATIN | 100353151 |
| 10381044 | 10056749 | 1.61 | 51.7 | Palliative (P) | 2020-06-30 | 2020-07-07 | Trifluridine + Tipiracil | 02 | N | TIPIRACIL + TRIFLURIDINE | 100273237 |
| 10381113 | 10056750 | 1.69 | 63.1 | null | 2018-08-26 | 2018-08-26 | CYCLOPHOSPHAMIDE + THALIDOMIDE | N | null | DABRAFENIB | 101216699 |
| 10381245 | 10056753 | 1.84 | 69.1 | null | 2019-08-27 | 2020-02-12 | Azacitidine | 01 | null | AZACITIDINE | 100594412 |
| 10381607 | 10056756 | 1.56 | 80 | Palliative (P) | 2014-10-27 | 2017-04-06 | Chlorambucil | 02 | N | CHLORAMBUCIL | 100997509 |
| 10381617 | 10056757 | 1.67 | 67 | null | 2019-09-02 | 2019-09-09 | DABRAFENIB + TRAMETINIB | 02 | null | NIRAPARIB | 101270869 |
| 10381819 | 10056760 | 1.68 | null | Palliative (P) | 2019-03-15 | 2019-03-29 | CISPLATIN + VINORELBINE | N | N | CAPECITABINE + IRINOTECAN | 100626227 |
| 10382031 | 10056761 | 1.58 | 85.8 | Palliative (P) | 2019-12-09 | 2019-12-09 | Bortezomib + CYCLOPHOSPHAMIDE | 02 | N | BORTEZOMIB + CYCLOPHOSPHAMIDE | 101623011 |
| 10382128 | 10056762 | 1.49 | null | null | 2018-10-10 | 2018-10-13 | CETUXIMAB + IRINOTECAN + MDG | N | null | VINORELBINE | 100329831 |
| 10382141 | 10056763 | 1.5 | 81 | Palliative (P) | 2017-04-17 | 2017-05-15 | Cisplatin + Radiotherapy | 02 | N | NIRAPARIB | 100206255 |
| 10382195 | 10056764 | 1.58 | 93.5 | null | 2017-06-11 | 2017-11-28 | Vinorelbine IV | 02 | null | CABOZANTINIB | 100000550 |
| 10382199 | 10056765 | 1.68 | 56.55 | null | 2020-05-16 | 2020-05-16 | Palbociclib | null | null | PALBOCICLIB | 100451734 |
| 10382416 | 10056766 | 1.88 | 70.3 | Neo-adjuvant (N) | 2017-04-29 | 2017-04-30 | Trifluridine + Tipiracil | 02 | N | TIPIRACIL + TRIFLURIDINE | 100292915 |
| 10382510 | 10056767 | 1.58 | 75 | null | null | 2017-04-21 | Gemcitabine weekly | 02 | null | GEMCITABINE | 101256055 |
| 10382697 | 10056769 | 1.82 | 64.1 | null | 2020-09-16 | 2020-10-12 | Bortezomib + CYCLOPHOSPHAMIDE | 02 | null | BORTEZOMIB + CYCLOPHOSPHAMIDE | 100137373 |
| 10382751 | 10056771 | 1.69 | 68.4 | null | 2018-12-28 | 2019-01-22 | Melphalan IV High dose | 02 | null | MELPHALAN | 100074279 |
| 10382905 | 10056772 | 1.71 | 97.7 | Palliative (P) | 2017-11-14 | 2019-03-03 | CISPLATIN + VINORELBINE | 02 | N | ACALABRUTINIB | 101547792 |
| 10382941 | 10056773 | 1.72 | 78 | Curative (C) | 2020-02-28 | 2020-11-01 | Acalabrutinib | 2 | N | ACALABRUTINIB | 100631479 |
| 10383005 | 10056775 | 1.75 | 85.7 | null | 2020-10-05 | 2020-12-29 | Gemcitabine 1000mg/m2 D1 8 15 | null | null | GEMCITABINE | 101551163 |
| 10383158 | 10056778 | 1.7 | 71.4 | null | 2018-12-20 | 2019-06-04 | Bortezomib (weekly) | N | null | BORTEZOMIB | 100700369 |
| 10383295 | 10056779 | 1.79 | 91.4 | null | 2021-03-23 | 2021-04-06 | CYCLOPHOSPHAMIDE | 02 | null | CYCLOPHOSPHAMIDE | 100508251 |
| 10383460 | 10056782 | 0 | 56.35 | Palliative (P) | 2016-07-21 | 2016-08-04 | BUSULFAN | 02 | N | DABRAFENIB | 100467627 |
| 10383508 | 10056783 | 1.66 | 61.55 | 03 | 2019-06-25 | 2019-07-18 | Cyclophosphamide Weekly PO | 02 | N | CYCLOPHOSPHAMIDE | 101574056 |
| 10383748 | 10056785 | 1.61 | null | Palliative (P) | null | 2018-10-30 | Cisplatin + Vinorelbine (PO) | N | N | ACALABRUTINIB | 101258931 |
| 10383758 | 10056786 | 1.82 | 74.8 | null | 2018-02-13 | 2018-02-19 | Gemcitabine 1000mg/m2 D1 8 15 | 02 | null | GEMCITABINE | 100732005 |
| 10383761 | 10056787 | 1.74 | 46 | Palliative (P) | null | 2018-12-17 | CAPECITABINE + IRINOTECAN | 02 | N | VINORELBINE | 101217063 |
| 10383819 | 10056788 | 1.66 | 87.4 | 03 | 2020-08-15 | 2020-08-23 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 02 | N | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 100441465 |
| 10384006 | 10056791 | 1.7 | 64 | null | 2017-11-13 | 2017-12-06 | BORTEZOMIB + THALIDOMIDE | N | null | CETUXIMAB | 101054517 |
| 10384137 | 10056793 | 1.4 | 75.6 | Palliative (P) | 2020-04-23 | 2020-10-01 | BENDAMUSTINE + POLATUZUMAB VEDOTIN + RITUXIMAB | 02 | N | CISPLATIN | 101193089 |
| 10384189 | 10056794 | 0 | 83.5 | Palliative (P) | 2019-04-30 | 2019-05-01 | Melphalan oral | 02 | N | MELPHALAN | 101221939 |
| 10384203 | 10056795 | 1.71 | 58.9 | Curative (C) | 2019-02-18 | 2019-02-28 | GEMCITABINE | 02 | N | GEMCITABINE | 101617501 |
| 10384229 | 10056796 | 1.57 | 72.1 | Palliative (P) | 2021-07-06 | 2021-07-13 | CYCLOPHOSPHAMIDE | 02 | N | CYCLOPHOSPHAMIDE | 100522811 |
| 10384319 | 10056797 | 1.56 | 72.3 | Adjuvant (A) | 2019-10-12 | 2019-10-14 | null | N | N | CISPLATIN | 100176167 |
| 10384394 | 10056798 | 1.72 | null | Palliative (P) | 2017-04-19 | 2017-04-30 | CHLORAMBUCIL + OBINUTUZUMAB | 02 | N | CHLORAMBUCIL + OBINUTUZUMAB | 101024230 |
| 10384452 | 10056799 | 1.68 | 65 | Palliative (P) | 2019-03-20 | 2019-05-23 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 02 | N | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 101506952 |
| 10384537 | 10056802 | 1.79 | 113.4 | Neo-adjuvant (N) | 2021-11-08 | 2021-11-12 | Palbociclib | 99 | N | PALBOCICLIB | 101390387 |
| 10384653 | 10056804 | 1.61 | 54 | Palliative (P) | 2019-12-22 | 2020-01-13 | CABOZANTINIB | 02 | N | CAPECITABINE + IRINOTECAN | 101593480 |
| 10384939 | 10056806 | 1.66 | 57.5 | null | 2017-10-10 | 2017-11-29 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | ACALABRUTINIB | 100235927 |
| 10385116 | 10056808 | 1.77 | 71 | null | null | 2020-06-13 | BORTEZOMIB + THALIDOMIDE | 02 | null | VINORELBINE | 101000241 |
| 10385524 | 10056811 | 1.68 | 69.4 | null | 2012-10-13 | 2019-12-15 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | DABRAFENIB | 100116411 |
| 10385581 | 10056812 | 1.63 | 83 | 03 | 2012-12-20 | 2021-04-17 | BENDAMUSTINE + POLATUZUMAB VEDOTIN + RITUXIMAB | 02 | N | PERTUZUMAB + TRASTUZUMAB | 101115682 |
| 10385729 | 10056813 | 1.83 | 81.2 | null | 2019-09-20 | 2019-09-21 | Capecitabine (21 day) + Irinotecan | null | null | CISPLATIN + GEMCITABINE | 101066777 |
| 10385774 | 10056814 | 1.56 | 63 | Palliative (P) | 2021-04-08 | 2021-04-09 | Bortezomib + Panobinostat | 02 | N | BORTEZOMIB + PANOBINOSTAT | 101162058 |
| 10385898 | 10056815 | 1.76 | 69 | Palliative (P) | 2016-07-12 | 2016-07-13 | CHLORAMBUCIL + OBINUTUZUMAB | 02 | N | CHLORAMBUCIL + OBINUTUZUMAB | 101113605 |